alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2016106EN.01003401.xml

| 21.3.2016 | EN | Official Journal of the European Union | C 106/34 |
| --- | --- | --- | --- |

21.3.2016

EN

Official Journal of the European Union

C 106/34

---

Judgment of the General Court of 5 February 2016 — Airpressure Bodyforming v OHIM (Slim legs by airpressure bodyforming)

(Case T-842/14) (1)

1

((Community trade mark - Application for Community word mark Slim legs by airpressure bodyforming - Refusal of registration by the examiner - Absolute grounds for refusal - Descriptive character - Lack of descriptive character - Article 7(1)(b) and (c) of Regulation (EC) No 207/2009))

(2016/C 106/38)

Language of the case: German

Parties

Parties

Applicant: Airpressure Bodyforming GmbH (Berchtesgaden, Germany) (represented by: S. Merz, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: C. Martini and M. Fischer, acting as Agents)

Defendant:

Re:

Re:

Action brought against the decision of the Fifth Board of Appeal of OHIM of 29 October 2014 (Case R 1570/2014-5) concerning an application for registration of the word sign Slim legs by airporessure bodyforming as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Airpressure Bodyforming GmbH to pay the costs. |
| --- | --- |

2.

Orders Airpressure Bodyforming GmbH to pay the costs.

---

(1)  OJ C 65, 23.3.2015.

1

---
# C_2017078EN.01001901.xml

| 13.3.2017 | EN | Official Journal of the European Union | C 78/19 |
| --- | --- | --- | --- |

13.3.2017

EN

Official Journal of the European Union

C 78/19

---

Judgment of the General Court of 26 January 2017 — TV1 v Commission

(Case T-700/14) (1)

1

((Public service contracts - Tendering procedure - Supply of integrated audiovisual production, dissemination and archiving services - Rejection of the tender of one tenderer - Contract awarded to another tenderer - Offer abnormally low - Obligation to request further clarification - Obligation to state reasons - Transparency - Equal treatment and non-discrimination - Manifest error of assessment))

(2017/C 078/25)

Language of the case: German

Parties

Parties

Applicant: TV1 GmbH (Unterföhring, Germany) (represented by: C. Scherer–Leydecker, J. Mey and A. Rausch, lawyers)

Applicant:

Defendant: European Commission (represented by: F. Moro and M. Noll-Ehlers initially, then F. Moro and T. Maxian Rusche and, lastly, T. Maxian Rusche and A. Katsimerou, Agents)

Defendant:

Re:

Re:

Application based on Article 263 TFEU and seeking annulment of the Commission’s decision rejecting the tender submitted by the applicant for Lot No. 4, entitled ‘streaming, compression, hosting and content delivery’ in the call for tenders bearing reference PO/2014 — 03/A4 and concerning ‘[i]ntegrated audiovisual production, dissemination and archiving services’, of the decision by which the Commission awarded that lot to the successful tenderer and of the contract for the supply of services concluded between the Commission and the successful tenderer.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders TV1 GmbH to pay the costs. |
| --- | --- |

2.

Orders TV1 GmbH to pay the costs.

---

(1)  OJ C 409, 17.11.2014.

1

---
```

[115th Congress Public Law 290]
[From the U.S. Government Publishing Office]

[[Page 132 STAT. 4374]]

Public Law 115-290
115th Congress

                                 An Act

 
To designate the facility of the United States Postal Service located at 
  511 East Walnut Street in Columbia, Missouri, as the ``Spc. Sterling 
  William Wyatt Post Office Building''. <<NOTE: Dec. 6, 2018 -  [H.R. 
                                4960]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. SPC. STERLING WILLIAM WYATT POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 511 East Walnut Street in Columbia, Missouri, shall be known 
and designated as the ``Spc. Sterling William Wyatt Post Office 
Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Spc. 
Sterling William Wyatt Post Office Building''.

    Approved December 6, 2018.

LEGISLATIVE HISTORY--H.R. 4960:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 164 (2018):
            July 16, considered and passed House.
            Nov. 15, considered and passed Senate.

                                  <all>
```
<PAGE>   1

                                                                    EXHIBIT 23.4

                           CONSENT OF PATENT COUNSEL

                               SEED AND BERRY LLP
                              6300 Columbia Center
                         Seattle, Washington 98104-7092

July 6, 1999

N2H2, Inc.
900 Fourth Avenue, Suite 3400
Seattle, WA 98164

We hereby consent to the reference to our firm under the caption "Legal Matters"
in the Registration Statement on Form S-1 (No. 333-78495) and related Prospectus
of N2H2, Inc. for the registration of 4,500,000 shares of its Common Stock.

                                          Sincerely,

                                          Seed and Berry LLP

                                          /s/ MICHAEL J. DONOHUE
                                          --------------------------------------
                                          Michael J. Donohue
EXHIBIT 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906

 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the quarter ended September 30, 2008 of Crimson Exploration Inc. (the “Issuer”).  The undersigned hereby certifies that the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 

| Date:

  | November 12, 2008

  |   |
|---------------|---------------------------|--------|
|          | /s/ E. Joseph Grady       |   |
| Name:         | E. Joseph Grady           |   |
| Title:        | Chief Financial Officer   |   |
|          |                      |   |
|          |                      |   |

 

A signed original of this written statement required by Section 906 has been provided to the Issuer and will be furnished to the Securities and Exchange Commission, or its staff, upon request.
EXHIBIT 32
----------




                             CERTIFICATIONS OF
            CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                    PURSUANT TO 18 U.S.C. SECTION 1350,
                 AS ADOPTED PURSUANT TO SECTION 906 OF THE
                        SARBANES-OXLEY ACT OF 2002
            ---------------------------------------------------



      The following statement is provided by the undersigned to accompany
the Quarterly Report on Form 10-Q for the quarter ended June 30, 2007,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed pursuant to any provision of the Securities Exchange Act of
1934 or any other securities law:

      Each of the undersigned certifies that the foregoing Report on
Form 10-Q fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of ALP Liquidating Trust.




                                         /s/   Gary Nickele
                                         ------------------------------
                                         Gary Nickele
                                         Chief Executive Officer




                                         /s/   Gailen J. Hull
                                         ------------------------------
                                         Gailen J. Hull
                                         Chief Financial Officer and
                                         Principal Accounting Officer
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 06-6168

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

WILLIAM DURAN SPEIGHT,

Defendant - Appellant.

Appeal from the United States District Court for the Southern

District of West Virginia, at Charleston. Joseph Robert Goodwin,

District Judge. (CR-99-189; 2:02-cv-01182)

Submitted: August 24, 2006 Decided: August 29, 2006

Before KING, SHEDD, and DUNCAN, Circuit Judges.

Dismissed by unpublished per curiam opinion.

William Duran Speight, Appellant Pro Se. Kasey Warner, United

States Attorney, Charleston, West Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
- 2 -

PER CURIAM:

William Duran Speight seeks to appeal the district

court’s order accepting the report and recommendation of the

magistrate judge and denying relief on his 28 U.S.C. § 2255 (2000)

motion. The order is not appealable unless a circuit justice or

judge issues a certificate of appealability. 28 U.S.C.

§ 2253(c)(1) (2000). A certificate of appealability will not issue

absent “a substantial showing of the denial of a constitutional

right.” 28 U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this

standard by demonstrating that reasonable jurists would find that

any assessment of the constitutional claims by the district court

is debatable or wrong and that any dispositive procedural ruling by

the district court is likewise debatable. Miller-El v. Cockrell,

537 U.S. 322, 336-38 (2003); Slack v. McDaniel, 529 U.S. 473, 484

(2000); Rose v. Lee, 252 F.3d 676, 683-84 (4th Cir. 2001). We have

independently reviewed the record and conclude that Speight has not

made the requisite showing. Accordingly, we deny a certificate of

appealability and dismiss the appeal. We dispense with oral

argument because the facts and legal contentions are adequately

presented in the materials before the court and argument would not

aid the decisional process.

DISMISSED
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.5850 Automated slide spinner. ( a ) *Identification.* An automated slide spinner is a device that prepares automatically a blood film on a microscope slide using a small amount of peripheral blood (blood circulating in one of the body's extremities, such as the arm).
( b ) *Classification.* Class I (general controls). This device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.
[45 FR 60603, Sept. 12, 1980, as amended at 54 FR 25045, June 12, 1989; 66 FR 38790, July 25, 2001]
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000813897
<NAME> PSH MASTER L.P.I.
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                         184,837
<SECURITIES>                                         0
<RECEIVABLES>                                1,136,311
<ALLOWANCES>                                         0
<INVENTORY>                                     99,326
<CURRENT-ASSETS>                             2,666,810
<PP&E>                                      58,220,740
<DEPRECIATION>                              21,841,366
<TOTAL-ASSETS>                              40,475,575
<CURRENT-LIABILITIES>                        3,035,094
<BONDS>                                     46,105,667
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                 (8,665,186)
<TOTAL-LIABILITY-AND-EQUITY>                40,475,575
<SALES>                                     16,691,801
<TOTAL-REVENUES>                            16,703,143
<CGS>                                                0
<TOTAL-COSTS>                               13,545,148
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           3,579,502
<INCOME-PRETAX>                              (421,507)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (421,507)
<EPS-PRIMARY>                                    (.13)
<EPS-DILUTED>                                    (.13)
        

</TABLE>
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.90 β-Apo-8′-carotenal. ( a ) *Identity.* ( 1 ) The color additive is β-apo-8′-carotenal.
( 2 ) Color additive mixtures for food use made with β-apo-8′-carotenal may contain only diluents that are suitable and that are listed in this subpart as safe in color additive mixtures for coloring foods.
( b ) *Specifications.* β-Apo-8′-carotenal shall conform to the following specifications: Physical state, solid. 1 percent solution in chloroform, clear. Melting point (decomposition), 136 °C.-140 °C. (corrected). Loss of weight on drying, not more than 0.2 percent. Residue on ignition, not more than 0.2 percent. Lead (as Pb), not more than 10 parts per million. Arsenic (as As), not more than 1 part per million. Assay (spectrophotometric), 96-101 percent.
( c ) *Uses and restrictions.* The color additive β-apo-8′-carotenal may be safely used for coloring foods generally, subject to the following restrictions: ( 1 ) The quantity of β-apo-8′-carotenal does not exceed 15 milligrams per pound of solid or semisolid food or 15 milligrams per pint of liquid food.
( 2 ) It may not be used to color foods for which standards of identity have been promulgated under section 401 of the act unless added color is authorized by such standards.
( d ) *Labeling.* The label of the color additive and any mixtures prepared therefrom and intended solely or in part for coloring purposes shall conform to the requirements of § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health and therefore batches thereof are exempt from the certification requirements of section 721(c) of the act.
Editorial Note on Part 860
Editorial Note: Nomenclature changes to part 860 appear at 73 FR 35341, June 23, 2008, and at 86 FR 54846, Oct. 5, 2021.

§ 860.15 Exemptions from sections 510, 519, and 520(f) of the Federal Food, Drug, and Cosmetic Act. ( a ) A panel recommendation to the Commissioner that a device be classified or reclassified into class I will include a recommendation as to whether the device should be exempted from some or all of the requirements of one or more of the following sections of the Federal Food, Drug, and Cosmetic Act: Section 510 (registration, product listing, and premarket notification), section 519 (records and reports) and section 520(f) (good manufacturing practice requirements of the quality system regulation), and, in the case of a recommendation for classification into class II, whether the device should be exempted from the premarket notification requirement under section 510.
( b ) A regulation or an order classifying or reclassifying a device into class I will specify which requirements, if any, of sections 510, 519, and 520(f) of the Federal Food, Drug, and Cosmetic Act the device is to be exempted from or, in the case of a regulation or an order classifying or reclassifying a device into class II, whether the device is to be exempted from the premarket notification requirement under section 510, together with the reasons for such exemption.
( c ) The Commissioner will grant exemptions under this section only if the Commissioner determines that the requirements from which the device is exempted are not necessary to provide reasonable assurance of the safety and effectiveness of the device.
[83 FR 64455, Dec. 17, 2018]
Exhibit 31.1

CHIEF EXECUTIVE OFFICERS

CERTIFICATION UNDER

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Vincent J. Milano, President and Chief Executive Officer of the registrant, certify that:



| | 1. | I have reviewed this Annual Report on Form 10-K of ViroPharma Incorporated; and
| | -- | -------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                                     
|-------------------------------------
|/s/ VINCENT J. MILANO                
|Vincent J. Milano                    
|President and Chief Executive Officer

December 3,
2010
EX-4.2



 Exhibit 4.2 

INCORPORATED IN THE CAYMAN ISLANDS 

BRIGHT SCHOLAR EDUCATION HOLDINGS LIMITED 

SPECIMEN 
 This is to certify that 

                          
      of 
 is the registered shareholders of: 

 

							
	No. of Shares	  	Type of Share	  	Par Value	 
			
		  	Ordinary	  	US$	0.00001	 
			
	Date of Record	  	Certificate Number	  	% Paid	 
			
		  		  	 	100.00	 

 The above shares are subject to the Memorandum and Articles of Association of the Company and transferrable in
accordance therewith. 
 Given under the Common Seal of the Company 

 

							
	  
	 	DIRECTOR    	 	  
	 	SECRETARY
```

[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Page 10296]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4543]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 75 FR 7489-7490, dated February 19, 2010) is 
amended to reflect the reorganization of the Office of Compensation 
Analysis and Support, Office of the Director, National Institute for 
Occupational Safety and Health, Centers for Disease Control and 
Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title and mission statement for the 
Office of Compensation Analysis and Support (CCA2) and insert the 
following:
    Division of Compensation Analysis and Support (CCN). (1) Conducts a 
program in support of Federal rulemaking to promulgate science-based 
methods and guidelines mandated by the Energy Employees Occupational 
Illness Compensation Program Act of 2000 (known as the ``Act'') to 
estimate the occupational radiation doses of claimants under the Act 
and evaluate the relationship between such doses and cancers incurred 
by the claimants; (2) develops and implements a program of science-
based analysis and policymaking by which the Secretary of Health and 
Human Services shall consider and issue determinations on petitions by 
classes of employees to be included as members of the Special Exposure 
Cohort established under the Act; and (3) conducts a program of 
individual dose reconstruction to estimate and report the radiation 
doses of claimants under the Act.

     Dated: February 23, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-4543 Filed 3-4-10; 8:45 am]
BILLING CODE 4163-18-M
```
#### § 660.52 Reference preparations.

Reference Anti-Human Globulin preparations shall be obtained from the Food and Drug Administration, Center for Biologics Evaluation and Research, Reagents and Standards Shipping, 10903 New Hampshire Ave., Bldg. 75, Rm. G704, Silver Spring, MD 20993-0002, and shall be used as described in the accompanying package insert for determining the potency of Anti-Human Globulin.

[50 FR 5579, Feb. 11, 1985, as amended at 50 FR 16474, Apr. 26, 1985; 51 FR 15611, Apr. 25, 1986; 55 FR 11015, Mar. 26, 1990; 67 FR 9587, Mar. 4, 2002; 70 FR 14986, Mar. 24, 2005; 80 FR 18093, Apr. 3, 2015]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements for the fiscal year ended March 31, 1997 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAR-31-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                         127,392
<SECURITIES>                                         0
<RECEIVABLES>                                  975,798
<ALLOWANCES>                                    17,000
<INVENTORY>                                    431,561
<CURRENT-ASSETS>                             2,567,748
<PP&E>                                         272,659
<DEPRECIATION>                                 220,353
<TOTAL-ASSETS>                               4,815,744
<CURRENT-LIABILITIES>                        1,546,340
<BONDS>                                              0
<PREFERRED-MANDATORY>                        1,193,090
<PREFERRED>                                          0
<COMMON>                                           908
<OTHER-SE>                                     745,537
<TOTAL-LIABILITY-AND-EQUITY>                 4,815,744
<SALES>                                      2,938,565
<TOTAL-REVENUES>                             2,938,565
<CGS>                                        4,335,447
<TOTAL-COSTS>                                4,335,447
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                17,000
<INTEREST-EXPENSE>                              79,732
<INCOME-PRETAX>                            (3,406,907)
<INCOME-TAX>                                     4,836
<INCOME-CONTINUING>                        (3,411,743)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,411,743)
<EPS-PRIMARY>                                   (5.98)
<EPS-DILUTED>                                   (5.98)
        

</TABLE>